The MMRF provides CME-accredited educational programs for healthcare professionals to learn more about multiple myeloma as well as current and emerging treatment options, including clinical trials from key leaders in myeloma. Access up-to-date information.
This activity for hematologist-oncologists, medical oncologists, and other health care providers involved in myeloma patient care uses evidence-based presentations and patient cases to examine how patient profile, clinical evidence, and risk-versus-benefit assessment influence the selection of the most appropriate myeloma therapies.
Utilizing evidence-based presentations and patient cases, our renowned myeloma experts tackle many of the fast-evolving areas of myeloma patient care: strategies for assessing patient prognosis and determining risk; selecting treatment combinations based on risk and patient-specific characteristics; the value of minimal residual disease in patient care; the role of novel agent/monoclonal antibody–based regimens for relapsed/refractory patients; and the latest trial data on oral small-molecule inhibitors and immune-oncology–based treatment regimens. Earn your credits now.